In the case of AML, Pan et al. discovered that the expression of Ring finger protein 220 (RNF220) was linked to negative outcomes, as it was inversely correlated with disease-free survival (DFS) and overall survival (OS) in AML patients. This evidence concerns the gene RNF220 and acute myeloid leukemia.